News Chart Modalis Therapeutics Corporation

Equities

4883

JP3922600006

Market Closed - Japan Exchange Other stock markets 07:00:00 13/06/2024 BST			5-day change	1st Jan Change
71 ^JPY	+1.43%		+2.90%	-42.74%

05-07	Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101	CI
04-30	Modalis Therapeutics Corporation to Present Data Supporting Development of Transformative Epigenome Editing Medicines for the Treatment of Muscular Dystrophy at the Global Cell & Gene Therapy Summit	CI

3f17d5f41ef8e4497eca2782.94u3_JZ061Idx4b86VctmKQ7aGrUhwcRDiR6MJdOzrE.pszRk-MBhQ1qs9nKriRMwexuIF2_sEV7RVNPR68jvf698_6r0zePZUuPww~348068340e68cf039f52fa33908c15c7